Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Gene Therapy
100%
Canine
100%
Krabbe Disease
100%
Globoid Cell Leukodystrophy
100%
Nervous System Diseases
100%
Peripheral Nervous System Diseases
100%
AAVrh10
100%
Peripheral Nervous System
50%
Adenovirus
33%
Central Nervous System
33%
Canine Model
33%
Virus Gene
33%
Galactosylceramidase
33%
Hematopoietic Stem Cell Transplantation
16%
Demyelination
16%
Standard of Care
16%
Attenuation
16%
Extended Life
16%
Intravenous Injection
16%
Neuropathology
16%
Dose-response
16%
Neurologic Disorders
16%
Therapeutic Effect
16%
Delayed Onset
16%
Symptom Onset
16%
Twitcher Mouse
16%
Lysosomal Enzymes
16%
Clinical Signs
16%
Pathological Changes
16%
Human Patients
16%
Clinical Disease Progression
16%
Intracerebroventricular Injection
16%
Biochemical Abnormalities
16%
Central Nervous System Impairment
16%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Krabbe Disease
100%
Canis
100%
Galactosylceramidase
66%
Adeno Associated Virus
66%
Canine Model
66%
Virus Gene
66%
Enzyme
33%
Hematopoietic Stem Cell Transplantation
33%
Lifespan
33%
Dose Response
33%
Twitcher Mouse
33%
Deficiency
33%
Medicine and Dentistry
Gene Therapy
100%
Neuropathy
100%
Globoid Cell Leukodystrophy
100%
Central Nervous System Disease
100%
Peripheral Nervous System
37%
Central Nervous System
37%
Galactosylceramidase
25%
Adeno-Associated Virus
25%
Virus Gene
25%
Hematopoietic Stem Cell Transplantation
12%
Disease Exacerbation
12%
Dose Response
12%
Lifespan
12%
Neurologic Disease
12%
Therapy Effect
12%
Neuropathology
12%
Demyelination
12%
Lysosome Enzyme
12%
Intracerebroventricular Drug Administration
12%
Diseases
12%
Intravenous Injection
12%
Neuroscience
Leukodystrophy
100%
Central Nervous System
100%
Krabbe Disease
100%
Neuropathy
100%
Peripheral Nervous System
50%
Galactosylceramidase
33%
Adeno-Associated Virus
33%
Virus Gene
33%
Lysosome Enzyme
16%
Hematopoietic Cell
16%